🇨🇦 Pluvicto in Canada

Pluvicto (Lutetium (177Lu) vipivotide tetraxetan) regulatory status in Canada.

Marketing authorisation

Pluvicto in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Pluvicto approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pluvicto in Canada?

Aaa Usa Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.